title: Plasma and cerebrospinal pharmacokinetics and pharmacodynamics in subjects taking lopinavir/ritonavir.
authors.forename: Troy M
authors.initials: TM
authors.lastname: Martin
authors.forename: Gene D
authors.initials: GD
authors.lastname: Morse
authors.forename: Jaclynn
authors.initials: J
authors.lastname: Kurpewski
authors.forename: Robin
authors.initials: R
authors.lastname: Difrancesco
authors.forename: Angela M
authors.initials: AM
authors.lastname: Caliendo
authors.forename: Timothy P
authors.initials: TP
authors.lastname: Flanigan
authors.forename: Karen T
authors.initials: KT
authors.lastname: Tashima
mesh_terms: D000328:Adult; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000493:pharmacokinetics*; D006801:Humans; D061466:Lopinavir; D008297:Male; D011744:Pyrimidinones / Q000493:pharmacokinetics*; D019438:Ritonavir / Q000493:pharmacokinetics*
chemical_list: D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D061466:Lopinavir; D019438:Ritonavir